Boston Scientific rides on cardiovascular device growth with FARAPULSE and WATCHMAN momentum, but margin pressure and weaker estimates cloud the…
Boston Scientifics Neuromodulation unit posts 15% organic sales growth in Q1, fueled by pain management gains, the acquisition of Nalu…
Intuitive Surgicals strong Q1 results, rising procedures, and raised outlook highlight accelerating growth, while Boston Scientific faces headwinds and tempered…
On April 22, 2026, investors weigh a rare combo of earnings strength and softer long-term targets reshaping this medtech leader’s…
NEW YORK — The U.S. stock market rallied to more records Wednesday after GE Vernova, Boston Scientific and other big…
Medical device maker Boston Scientific cut its annual profit forecast on Wednesday, overshadowing a first-quarter earnings and revenue beat, while…
Boston Scientific (BSX) delivered earnings and revenue surprises of +0.59% and +0.37%, respectively, for the quarter ended March 2026. Do…
Boston Scientific meets Q1 EPS estimates, posts 11.6% revenue growth and beats sales estimates, but cuts 2026 outlook; shares still…
Boston Scientific heads into Q1 earnings with strong Cardiovascular momentum and steady MedSurg growth, as estimates point to solid revenue…
Boston Scientific (BSX) closed the most recent trading day at $64.61, moving +1.24% from the previous trading session.…
Boston Scientific (BSX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming…
Boston Scientific (BSX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients…
New class action for Boston Scientific (BSX) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff…
Boston Scientific (BSX) closed at $61.28 in the latest trading session, marking a -2.05% move from the prior day.…
In the most recent trading session, Boston Scientific (BSX) closed at $61.86, indicating a -1.17% shift from the previous trading…
Boston Scientific stock hits 52-week low at 61.23 USD…
New class action for Boston Scientific (BSX) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff…
…
In the closing of the recent trading day, Boston Scientific (BSX) stood at $62.93, denoting a -9.02% move from the…
Today, March 30, 2026, investors send Boston Scientific shares lower as they dig deeper into the companys latest trial update.…
Boston Scientific stock tumbles 9% on trial results…
These are the stocks posting the largest moves in midday trading.…
Raymond James downgrades Boston Scientific but long-term story remains intact…
New class action for Boston Scientific (BSX) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff…
Boston Scientific (BSX) concluded the recent trading session at $68.15, signifying a -2% move from its prior days close.…
Boston Scientific (BSX) closed the most recent trading day at $71.2, moving +2.02% from the previous trading session.…
The case alleges Boston Scientific misled investors about its US EP segments growth and competitive risks.…
Boston Scientific (BSX) closed the most recent trading day at $68.55, moving 1.55% from the previous trading session.…
Image source: The Motley Fool.DATEWednesday, March 11, 2026 at 5 p.m. ETCALL PARTICIPANTSChief Executive Officer — Randy MillsChief Financial Officer…
New York (www.aktiencheck.de) - Boston Scientific-Aktienanalyse von Citi:Die Analysten von Citi senken das Kursziel für die Aktie von Boston Scientific…
Boston Scientific (BSX) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates…
The latest trading day saw Boston Scientific (BSX) settling at $76.85, representing a +1.45% change from its previous close.…
Abbott edges out Boston Scientific in the MedTech faceoff, with valuation appeal, strong CGM momentum and strategic deals boosting its…
Image source: The Motley Fool.DATETuesday, Feb. 17, 2026 at 8:30 a.m. ETCALL PARTICIPANTSChief Executive Officer — David A. RosaChief Financial…
Image source: The Motley Fool.DateTuesday, Feb. 10, 2026 at 5 p.m. ETCall participantsChief Executive Officer — Bernard ZovighianChief Financial Officer…
Few analysts foresaw the disappointing results and profit forecast that sent Boston Scientific Corp.’s shares plummeting nearly 20% this week.…
Whether youre a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top…
Ill be keeping a close eye on Boston Scientific stock following the markets peculiar reaction to its solid earnings report.…
Image source: The Motley Fool.DATEWednesday, February 4, 2026, 8 a.m. ETCALL PARTICIPANTSChairman and Chief Executive Officer — Michael F. MahoneyExecutive…
Boston Scientific Corp forecast modest 2026 revenue growth and profit just below Wall Street expectations on Wednesday, overshadowing a strong…
Image source: The Motley Fool.DateThursday, January 29, 2026 at 4:30 p.m. ETCall participantsChair and Chief Executive Officer — Kevin A.…
In the closing of the recent trading day, Boston Scientific (BSX) stood at $92.51, denoting a +1.34% move from the…
Boston Scientific ratings affirmed by Fitch, outlook positive…
New York (www.aktiencheck.de) - Boston Scientific-Aktienanalyse von Oppenheimer:Die Analysten von Oppenheimer haben das Kursziel für die Aktie von Boston Scientific…
…
Bad Marienberg (www.aktiencheck.de) - Boston Scientific-Aktie nach Milliardenübernahme unter Druck – Was Anleger jetzt wissen müssen ????Am Dienstagabend war es…
Wien (www.aktiencheck.de) - Aktien aus der Halbleiterbranche wurden gestern von TSMC (+3%) beflügelt, so die Analysten der Raiffeisen Bank International…
…
Boston Scientific said on Thursday it will buy Penumbra in a deal valued at about $14.5 billion.…
Boston Scientific Corp (NYSE:BSX, XETRA:BSX) announced a definitive agreement to acquire medical device company Penumbra (NYSE:PEN) in a cash and stock...…